These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 27265474)

  • 21. Clinicopathologic Characteristics and Patient Outcomes of Phyllodes Tumors: A Single Institution Experience.
    Mohan SC; Tseng J; Angarita S; Marumoto A; Dadmanesh F; Amersi F; Giuliano A; Chung A
    Am Surg; 2021 Dec; 87(10):1533-1538. PubMed ID: 34689588
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Surgery for phyllodes tumour of the breast. What should be surgical margins?
    Tukenmez M; Mollavelioglu B; Onder S; Emiroglu S; Velidedeoglu M; Ergun S; Cabioglu N; Muslumanoglu M
    ANZ J Surg; 2023 Jan; 93(1-2):257-262. PubMed ID: 36629354
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phyllodes Tumors-The Predictors and Detection of Recurrence.
    Lim RS; Cordeiro E; Lau J; Lim A; Roberts A; Seely J
    Can Assoc Radiol J; 2021 May; 72(2):251-257. PubMed ID: 32090614
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinicopathologic risk factors for the local recurrence of phyllodes tumors of the breast.
    Jang JH; Choi MY; Lee SK; Kim S; Kim J; Lee J; Jung SP; Choe JH; Kim JH; Kim JS; Cho EY; Lee JE; Nam SJ; Yang JH
    Ann Surg Oncol; 2012 Aug; 19(8):2612-7. PubMed ID: 22476816
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of clinical characteristics between benign borderline and malignant phyllodes tumors of the breast.
    Wang H; Wang X; Wang CF
    Asian Pac J Cancer Prev; 2014; 15(24):10791-5. PubMed ID: 25605178
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predictive factors of local recurrence and survival following primary surgical treatment of phyllodes tumors of the breast.
    Abdalla HM; Sakr MA
    J Egypt Natl Canc Inst; 2006 Jun; 18(2):125-33. PubMed ID: 17496937
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Characteristics of Local Recurrence After Breast-Conserving Surgery Alone for Malignant and Borderline Phyllodes Tumors of the Breast (KROG 16-08).
    Choi N; Kim K; Shin KH; Kim Y; Moon HG; Park W; Choi DH; Kim SS; Ahn SD; Kim TH; Chun M; Kim YB; Kim S; Choi BO; Kim JH
    Clin Breast Cancer; 2019 Oct; 19(5):345-353.e2. PubMed ID: 31103280
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Management and outcomes of phyllodes tumours - 10 year experience.
    Boland PA; Ali Beegan A; Stokes M; Kell MR; Barry JM; O'Brien A; Walsh SM
    Breast Dis; 2021; 40(3):171-176. PubMed ID: 33749634
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cystosarcoma phyllodes: Pathological enigma: A retrospective review of 162 cases.
    Narayanakar RP; Gangaiah DM; Althaf S; Dev K; Kurpad V; Gurawalia J
    Indian J Cancer; 2015; 52(3):365-8. PubMed ID: 26905140
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Time to revise classification of phyllodes tumors of breast? Results of a French multicentric study.
    Adam MJ; Bendifallah S; Kalhorpour N; Cohen-Steiner C; Ropars L; Mahmood A; Rousseau C; Leveque J; Nyangoh Timoh K; Der Some A; Ouldamer L; Legendre G; Ballester M; Daraï E; Canlorbe G; Lavoue V
    Eur J Surg Oncol; 2018 Nov; 44(11):1743-1749. PubMed ID: 30195948
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Therapy concept in phyllodes tumors of the breast].
    Oehme J; Siemer P
    Zentralbl Chir; 1998; 123 Suppl 5():100-1. PubMed ID: 10063587
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phyllodes tumor of the breast clinical experience and outcomes: A retrospective cohort tertiary hospital experience.
    Alkushi A; Arabi H; Al-Riyees L; Aldakheel AM; Al Zarah R; Alhussein F; Altamimi AM; Alsulaiman YA; Omair A
    Ann Diagn Pathol; 2021 Apr; 51():151702. PubMed ID: 33472142
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Contemporary Multi-Institutional Cohort of 550 Cases of Phyllodes Tumors (2007-2017) Demonstrates a Need for More Individualized Margin Guidelines.
    Rosenberger LH; Thomas SM; Nimbkar SN; Hieken TJ; Ludwig KK; Jacobs LK; Miller ME; Gallagher KK; Wong J; Neuman HB; Tseng J; Hassinger TE; King TA; Jakub JW
    J Clin Oncol; 2021 Jan; 39(3):178-189. PubMed ID: 33301374
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phyllodes tumor of the breast.
    Belkacémi Y; Bousquet G; Marsiglia H; Ray-Coquard I; Magné N; Malard Y; Lacroix M; Gutierrez C; Senkus E; Christie D; Drumea K; Lagneau E; Kadish SP; Scandolaro L; Azria D; Ozsahin M
    Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):492-500. PubMed ID: 17931796
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phyllodes tumors of the breast: a case series of 106 patients.
    Ben Hassouna J; Damak T; Gamoudi A; Chargui R; Khomsi F; Mahjoub S; Slimene M; Ben Dhiab T; Hechiche M; Boussen H; Rahal K
    Am J Surg; 2006 Aug; 192(2):141-7. PubMed ID: 16860620
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Management of Benign Phyllodes Tumors: A Dutch Population-Based Retrospective Cohort Between 1989 and 2022.
    van Olmen JP; Beerthuizen AWJ; Bekers EM; Viegen I; Drukker CA; Vrancken Peeters MTFD; Bartels SAL; van Duijnhoven FH
    Ann Surg Oncol; 2023 Dec; 30(13):8344-8352. PubMed ID: 37639031
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mammary phyllodes tumour: a 15-year multicentre clinical review.
    Co M; Chen C; Tsang JY; Tse G; Kwong A
    J Clin Pathol; 2018 Jun; 71(6):493-497. PubMed ID: 29146885
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-Term Outcomes After Surgical Treatment of Malignant/Borderline Phyllodes Tumors of the Breast.
    Spanheimer PM; Murray MP; Zabor EC; Stempel M; Morrow M; Van Zee KJ; Barrio AV
    Ann Surg Oncol; 2019 Jul; 26(7):2136-2143. PubMed ID: 30783853
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phyllodes tumours of the breast: Outcomes and recurrence after excision.
    Wen B; Mousadoust D; Warburton R; Pao JS; Dingee C; Chen L; McKevitt E
    Am J Surg; 2020 May; 219(5):790-794. PubMed ID: 32145921
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Single-institution outcomes after excision of benign phyllodes tumors: low recurrence risk even with positive margins.
    Balogun Z; Steiman JG; Schwartz JL; Lee JS; Soran A; Johnson RR; McAuliffe PF; Diego EJ
    Breast Cancer Res Treat; 2023 Apr; 198(3):569-572. PubMed ID: 36807012
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.